Skip directly to content

AI Impact on ESG Investing

Speaker: Grant Fuller

CQF Institute is proud to bring you a free talk with Grant Fuller on AI Impact on ESG Investing.

Abstract 

Sustainable, responsible, and impact investing (SRI) is an investment discipline which incorporates environmental, social, and corporate governance (ESG) criteria to enhance long-term risk management, competitive financial returns and positive societal impact.
The first part of this talk looks at some recent academic and industry research applying machine learning to better understand the relationship between ESG factors, returns and risk. 
The second part of the talk moves away from more traditional applications of machine learning in the domain, and looks at how the nature of SRI and ESG increases the risk of ignominy for both institutional investors and issuers, having a tangible effect on capital flows, income and reputation. Case studies will be used to illustrate how AI is leveraging natural biases in institutional views and expectations.
Frequently used to enhance corporate insight of investor appetite, behaviour and vulnerabilities, AI has become part of activist and defensive campaigns.

Speaker Bio

Grant Fuller, CEO, Irithmics

Grant co-founded Irithmics in 2012. The firm's award-winning deep learning technology provides data and services to institutional investors, asset managers, exchanges, corporates, brokers and research analysts. Previously part of Ernst & Young's fund advisory practice, Grant also helped develop Bloomberg's successful hedge fund trading and analytics technology, leading the firm's European and Asian AIM business. Prior to Bloomberg, Grant was part of RiskMetrics, establishing their European fund and asset management analytics and consulting capabilities. He holds a BSc in Chemistry from the University of St Andrews. He remained at St Andrews to undertake a PhD applying neural networks in chemistry, after which he joined academic research at Cambridge University, applying neural networks to public health epidemiology.